Advertisement Takeda to establish new vaccine business division - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Takeda to establish new vaccine business division

Takeda Pharmaceutical Company has announced its plan to establish a vaccine business division effective 1January 2012.

The Company has also appointed Rajeev Venkayya as its leader of the Division effective 15 January 2012.

Dr Venkayya currently serves as Director of Vaccine Delivery in the Global Health Program at the Bill & Melinda Gates Foundation.

Takeda chief medical and scientific officer Tadataka Yamada said that while the global vaccine market continues to expand as emerging countries grow, the short supply of affordable vaccines still poses a serious problem.